Blue Ash Therapeutics

Blue Ash Therapeutics, is a Cincinnati-based company founded to develop and commercialize acute-care cardiovascular drugs. The initial focus is the late-stage antiarrhythmic drug Azimilide as an adjunctive therapy in patients with implantable cardioverter-defibrillators (ICDs).


 

Get In Touch With Us